Reproductive Health & Justice FDA Adverse Event Data FOIA March 25, 2026 Rifan Muazin Advocacy Group Demands FDA Transparency on Mifepristone Safety Data Amidst Ongoing Legal Battles A prominent reproductive rights advocacy organization has formally requested detailed safety data pertaining to mifepristone, a medication…